eksentriline

Eksentriline is a medication used to treat attention deficit hyperactivity disorder (ADHD) in adults. It belongs to the class of stimulant medications, specifically a selective norepinephrine reuptake inhibitor (SNRI). The active ingredient in eksentriline is d-amphetamine, which is metabolized in the body to form the active form of the drug.

Eksentriline was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of ADHD in adults. It is available in tablet form and is typically taken once daily. The medication works by increasing the levels of norepinephrine, a neurotransmitter involved in attention and impulse control, in the brain.

Common side effects of eksentriline may include nausea, headache, and insomnia. Serious side effects are rare but can include seizures, high blood pressure, and cardiovascular problems. It is important to use eksentriline under the guidance of a healthcare professional, as it may not be suitable for everyone, particularly those with certain medical conditions or those who are pregnant or breastfeeding.

Eksentriline is not approved for use in children or adolescents. The safety and efficacy of the medication in these age groups have not been established. As with any medication, it is crucial to follow the prescribed dosage and to report any unusual symptoms or side effects to a healthcare provider.